Laurie J. Hall Trustee’s Lexicon Pharmaceuticals LXRX Stock Holding History

Laurie J. Hall Trustee’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-720	Closed	-$1K	–	294
2022 Q4	$1K	Sell	720 -420	-37%	-$894	﹤0.01%	300
2022 Q3	$3K	Sell	1,140 -510	-31%	-$1.41K	﹤0.01%	295
2022 Q2	$3K	Hold	1,650	–	–	﹤0.01%	298
2022 Q1	$3K	Hold	1,650	–	–	﹤0.01%	305
2021 Q4	$7K	Hold	1,650	–	–	﹤0.01%	287
2021 Q3	$8K	Sell	1,650 -1,230	-43%	-$5.05K	﹤0.01%	283
2021 Q2	$13K	Hold	2,880	–	–	﹤0.01%	275
2021 Q1	$17K	Buy	2,880 +1,550	+117%	+$10.7K	0.01%	272
2020 Q4	$5K	Buy	1,330 +980	+280%	+$1.87K	﹤0.01%	303
2020 Q3	$1K	Buy	+350	New	+$623	﹤0.01%	316
2019 Q4	$1K	Hold	230	–	–	﹤0.01%	327
2019 Q3	$1K	Hold	230	–	–	﹤0.01%	324
2019 Q2	$1K	Hold	230	–	–	﹤0.01%	327
2019 Q1	$1K	Hold	230	–	–	﹤0.01%	331
2018 Q4	$1K	Hold	230	–	–	﹤0.01%	329
2018 Q3	$2K	Hold	230	–	–	﹤0.01%	349
2018 Q2	$3K	Hold	230	–	–	﹤0.01%	340
2018 Q1	$2K	Hold	230	–	–	﹤0.01%	349
2017 Q4	$2K	Sell	230 -110	-32%	-$1.14K	﹤0.01%	352
2017 Q3	$4.18K	Hold	340	–	–	﹤0.01%	285
2017 Q2	$5.48K	Buy	+340	New	+$5.26K	﹤0.01%	279

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Laurie J. Hall Trustee's LXRX Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2023, closing a stake of 720 shares — an estimated $1K sold.

Laurie J. Hall Trustee first reported a position in LXRX in Q2 2017 and held it in 21 quarters. The position peaked at $17K in Q1 2021. 104 funds tracked by Wall St. Rank hold LXRX as of Q1 2023.

Laurie J. Hall Trustee reported no remaining Lexicon Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Laurie J. Hall Trustee sold 720 Lexicon Pharmaceuticals shares in Q1 2023, an estimated $1K.
Laurie J. Hall Trustee first reported a position in Lexicon Pharmaceuticals in Q2 2017 and held it in 21 quarters.
Laurie J. Hall Trustee's Lexicon Pharmaceuticals position peaked at $17K in Q1 2021.
104 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.